Measuring the value of the WHO Model list of essential medicines

Affiliations

¹ Public Administration and Governance, Faculty of Social Sciences, Oslo Metropolitan University, Pilestredet 35, 0166Oslo, Norway.
² Global Health Cluster, Norwegian Institute of Public Health, Oslo, Norway.
³ Department of Global Public Health and Primary Care, University of Bergen, Bergen, Norway.
⁴ Department of Pharmacy Practice and Clinical Pharmacy, University of Ghana, Accra, Ghana.
⁵ Centre for Epidemic Interventions Research, Norwegian Institute of Public Health, Oslo, Norway.

Editorial

Elizabeth F Peacocke et al. Bull World Health Organ. 2024.

. 2024 Oct 1;102(10):684-684A.

doi: 10.2471/BLT.24.292521.

¹ Public Administration and Governance, Faculty of Social Sciences, Oslo Metropolitan University, Pilestredet 35, 0166Oslo, Norway.
² Global Health Cluster, Norwegian Institute of Public Health, Oslo, Norway.
³ Department of Global Public Health and Primary Care, University of Bergen, Bergen, Norway.
⁴ Department of Pharmacy Practice and Clinical Pharmacy, University of Ghana, Accra, Ghana.
⁵ Centre for Epidemic Interventions Research, Norwegian Institute of Public Health, Oslo, Norway.

No abstract available

References

1. Piggott T, Moja L, Huttner B, Okwen P, Raviglione MCB, Kredog T, et al. WHO Model list of essential medicines: visions for the future. Bull World Health Organ. 2024.Oct 1;102(10):722.–.
1. Goroshko A, Riabtseva NNS. Can people afford to pay for health care? New evidence on financial protection in Ukraine. Copenhagen: the World Health Organization Regional Office for Europe; 2023.
1. Persaud N, Jiang M, Shaikh R, Bali A, Oronsaye E, Woods H, et al. Comparison of essential medicines lists in 137 countries. Bull World Health Organ. 2019. Jun 1;97(6):394–404C. 10.2471/BLT.18.222448 - DOI - PMC - PubMed
1. Piggott T, Nowak A, Brignardello-Petersen R, Cooke GS, Huttner B, Schünemann HJ, et al. Global status of essential medicine selection: a systematic comparison of national essential medicine lists with recommendations by WHO. BMJ Open. 2022. Feb 10;12(2):e053349. 10.1136/bmjopen-2021-053349 - DOI - PMC - PubMed
1. McGettigan P, Henry D. Use of non-steroidal anti-inflammatory drugs that elevate cardiovascular risk: an examination of sales and essential medicines lists in low-, middle-, and high-income countries. PLoS Med. 2013;10(2):e1001388. 10.1371/journal.pmed.1001388 - DOI - PMC - PubMed